A: When conolidine exhibits guarantee for extensive-phrase pain reduction, much more investigate is necessary to confirm its security about prolonged intervals. Most recently, it's been identified that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, https://bernardy035duj7.wikissl.com/user